Novacyt: shares take a beating
AIM’s top performer in 2020 has fallen back to earth after a disappointing trading update. Are the shares now a bargain or is there more trouble ahead? We offer our thoughts on this amazing little business.
The share price of Novacyt (LON: NCYT), the clinical diagnostics specialist and AIM’s top performer in 2020, tumbled 40% today on news that it is dispute with Department of Health and Social Care (DHSC).
Sign up and read the full article
Register to continue reading our content.
Already a member? Login
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.REGISTER FREE
More on Novacyt SA
AIM’s top performer in 2020 has fallen back to earth after a disappointing trading update. Are…
Bonkers Bargains, new Covid tests, kettle controls, video game developers and franchised lettings – such are…